Clinical Trials

Showing trials with last updates posted in 2026.

NCT03661307 | RECRUITING | PHASE1/PHASE2
73 participants

Quizartinib, Decitabine, and Venetoclax in Treating Participants With Untreated or Relapsed Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-20
Start Date:
2018-10-31
Completion:
2028-01-01
Conditions
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndrome
  • Recurrent Acute Myeloid Leukemia
  • Recurrent Myelodysplastic Syndrome
  • Refractory Acute Myeloid Leukemia
Interventions
  • DRUG
No Results Yet
NCT03471260 | RECRUITING | PHASE1/PHASE2
96 participants

Ivosidenib and Venetoclax With or Without Azacitidine in Treating Patients With IDH1 Mutated Hematologic Malignancies

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-20
Start Date:
2018-03-19
Completion:
2027-09-30
Conditions
  • Acute Myeloid Leukemia
  • Hematopoietic and Lymphoid System Neoplasm
  • Myelodysplastic Syndrome
  • Myeloproliferative Neoplasm
  • Recurrent Acute Myeloid Leukemia
  • Refractory Acute Myeloid Leukemia
Interventions
  • DRUG
No Results Yet
NCT03148106 | TERMINATED | NA
14 participants

Hand Rehabilitation Study for Stroke Patients

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-20
Start Date:
2017-04-04
Completion:
2025-12-02
Conditions
  • Upper Extremity Paresis
  • Disability Physical
  • Chronic Stroke
  • Motor Disorders
Interventions
  • DEVICE
No Results Yet
NCT03076697 | COMPLETED
472 participants

Smartphone Screening for Eye Diseases

Study Type:
OBSERVATIONAL
Last Updated:
2026-08-20
Start Date:
2015-04-16
Completion:
2019-05-15
Conditions
  • Diabetes Mellitus
  • Glaucoma
  • Age Related Macular Degeneration
  • ROP
  • Diabetic Retinopathy
  • Retinal Disease
Interventions
  • DIAGNOSTIC_TEST
No Results Yet
NCT02879695 | ACTIVE_NOT_RECRUITING | PHASE1
28 participants

Blinatumomab and Nivolumab With or Without Ipilimumab in Treating Patients With Poor-Risk Relapsed or Refractory CD19+ Precursor B-Lymphoblastic Leukemia

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-20
Start Date:
2017-10-25
Completion:
2023-05-22
Conditions
  • Recurrent B Acute Lymphoblastic Leukemia
  • Recurrent Mixed Phenotype Acute Leukemia
  • Refractory B Acute Lymphoblastic Leukemia
  • Refractory Mixed Phenotype Acute Leukemia
Interventions
  • PROCEDURE
  • BIOLOGICAL
NCT02511015 | COMPLETED
31 participants

Hereditary Parkinson s Disease Natural History Protocol

Study Type:
OBSERVATIONAL
Last Updated:
2026-08-20
Start Date:
2015-07-08
Completion:
2016-04-07
Conditions
  • Parkinson Disease 6, Early-Onset
  • Parkinson Disease (Autosomal Recessive, Early Onset) 7, Human
  • Parkinson Disease Autosomal Recessive, Early Onset
  • Parkinson Disease, Autosomal Recessive Early-Onset, Digenic, Pink1/Dj1
No Results Yet
NCT02392572 | TERMINATED | PHASE1/PHASE2
58 participants

ONC201 in Treating Patients With Relapsed or Refractory Acute Leukemia or High-Risk Myelodysplastic Syndrome

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-20
Start Date:
2015-11-03
Completion:
2026-08-14
Conditions
  • Recurrent Acute Lymphoblastic Leukemia
  • Recurrent Acute Myeloid Leukemia
  • Recurrent Myelodysplastic Syndrome
  • Refractory Acute Lymphoblastic Leukemia
  • Refractory Acute Myeloid Leukemia
  • Refractory Myelodysplastic Syndrome
Interventions
  • DRUG
No Results Yet
NCT02386800 | ACTIVE_NOT_RECRUITING | PHASE4
279 participants

CINC424A2X01B Rollover Protocol

Study Type:
INTERVENTIONAL
Last Updated:
2026-08-20
Start Date:
2015-03-05
Completion:
2032-04-05
Conditions
  • Primary Myelofibrosis
  • Polycythemia Vera
  • Graft Versus Host Disease
  • Acute Myeloid Leukemia
  • Thalassemia
Interventions
  • DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page